COMMON IMATINIB: A AFFORDABLE ALTERNATIVE?

The introduction of common imatinib represents a notable possibility for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, commonly known as Gleevec, carries a steep price label, frequently causing accessibility for some individuals. Off-brand versions,